Financial Results for the First Quarter of Fiscal Year Ending March 31, 2013
July 31, 2012
Exchange where listed: TSE

Name of listed company: TERUMO CORPORATION(URL http://www.terumo.com/): 4543: Yutaro Shintaku, President and Representative Director: Tetsuya Kumei, General Manager, Corporate Communication Dept.
: +81 / 3-6742-8550

Company code number
Representative:
Please address all communications toPhone

1. Consolidated financial highlights for the interim period ended June 2012
(From April 1, 2012 to June 30, 2012)(1) Consolidated financial results(Note: The amounts shown below ignore values of less than a million yen)

Net sales

Operating income(Millions of yen)Three months ended June, 2012
Three months ended June, 2011
(Notes) Comprehensive income:%

95,867
95,630(Millions of yen)%

15,481
17,3780.2
17.7

June 2012: （6,081）million yen (－%)

Ordinary income(Millions of yen)

12,981
16,868(10.9)
9.0

Net income%(Millions of yen)

8,159
9,772

(23.0)
34.4%(16.5)
11.1

June 2011: 5,914million yen (－%)
Net income per share,
fully diluted

Net income per share(Yen)

(Yen)

42.97
－
Three months ended June, 2012
51.46－
Three months ended June, 2011
(Note) Percentage represent increase (decrease) from the corresponding period in the prior fiscal year.

(2) Consolidated financial position(Note: The amounts shown below ignore values of less than a million yen)

Total assets

As at June 30, 2012
As at March 31, 2012

Net assets

Equity ratio

Net assets per share(Millions of yen)

(Millions of yen)%(Yen)

654,818
692,520342,278
352,53752.2
50.9

1,801.36
1,855.25(Note) Shareholders' equity : June 30, 2012: 342,040 million yen, March 31, 2012: 352,272 million yen.

2. Dividends
Cash dividends per share
4th quarter

1st quarter 2nd quarter 3rd quarter

Year ended March 31, 2012
Year ending March 31, 2013
Year ending March 31, 2013 (forecast)

total(Yen)

(Yen)

(Yen)

(Yen)

(Yen)

－－

17.00

－

22.00

39.00

22.00

－

22.00

44.00

(Note) Revise of dividends forecast : None

3. Consolidated forecast for the year ending March 2013 (From April 1, 2012 to March 31, 2013)
Net sales

Half year ending September, 2012
Year ending March, 2013

Operating income

Ordinary income

Net income
per share

Net income(Millions of yen)%

(Millions of yen)%

(Millions of yen)%

(Millions of yen)%

195,000
410,000

2.2
6.0

28,50060,000(17.7)(4.8)

27,50058,000(12.1)(2.0)

16,00034,000

(9.7)
40.7

(Yen)

84.26
179.06

1. Forecast for fiscal year ending March, 2013 which was announced on May 10, 2012 has not been revised.
(Assumed exchange rate for fiscal year ending March, 2013: USD1=JPY80, EUR1=JPY105)
2. Among the information that Terumo discloses, forecasts of financial performance on future projections contain potential risks and uncertainty since these areforecasts on projections made by Terumo based on limited information available at the moment of disclosure. Accordingly, it should be noted that actual results
may differ from those forecasts on projections due to various factors. Factors affecting to actual results include, but are not limited to, changes in economic
conditions surrounding Terumo, fluctuations of foreign exchange rates, and state of competition.

1

5. Consolidated Financial Statements(1) Consolidated Balance Sheets(Millions of yen)
As at March 31, 2012
Amount(Assets)
I Current assets%

256,867

As at June 30, 2012
Amount37.1%

232,815

Cash and deposits

78,767

62,693

Notes and accounts receivable-trade

91,80083,418Inventories

69,28071,556

Deferred tax assets

9,707

7,571

977

Other

8,543

8,519

Allowance for doubtful accounts(1,240)(1,022)Derivatives

%
35.6%

II Noncurrent assets

435,65262.9%

421,989

64.4%

1. Property, plant and equipment

131,75419.0%

131,308

20.0%

Buildings and structures

47,10847,602

Machinery, equipment and vehicles

38,43138,396

Land

21,29821,515

Lease assets

1,447

1,473

Construction in progress

15,24313,808

Other

8,225

8,512

2. Intangible assets

270,790

Goodwill

138,80939.1%

132,350

Customer Relationship

83,75879,677

Other

48,22247,191

33,106

Investment securities

20,387

18,901

Deferred tax assets

6,996

7,054

Other

5,722
－－

5,505
13

0.0%

692,520100.0%

654,818

100.0%

2

31,461

39.6%

3. Investments and other assets

III Deferred assets
Total assets

4.8%

259,218

4.8%

(Millions of yen)
As at March 31, 2012
Amount(Liabilities)
I Current liabilities%

157,997

22.8%

As at June 30, 2012
Amount%105,644

Notes and accounts payable-trade33,92033,483

Short-term loans payable

60,00025,209423

439

Income taxes payable

11,840

4,037

Deferred tax liabilities

2332

Provision for bonuses

5,048

2,510

127

31

7,027

5,722

840

420

38,74733,754

Lease obligations

Provision for directors' bonuses
Notes and accounts payable - facilities
Asset retirement obligations
Other

II Noncurrent liabilities

181,984

26.3%

206,895

Bonds payable

80,00080,000Long-term loans payable

50,00076,568999

1,042

Deferred tax liabilities

44,73642,459Provision for retirement benefits

1,538
202

1,681
199

153

154

4,354

4,789

Lease obligations

Provision for directors' retirement benefits
Asset retirement obligations
Other

Total liabilities
I Shareholders' equity

49.1%

312,54047.7%

381,34555.1%

385,32658.9%

38,716

38,716

Capital surplus

52,103

52,103Retained earnings

290,529294,511(3)(5)

II Accumulated other comprehensive income(29,073)

Valuation difference on available-for-sale securities
Deferred gains or losses on hedges
Foreign currency translation adjustment

III Minority interests
Total net assets
Total liabilities and net assets

3

31.6%

339,982

Capital stock

Treasury stock

16.1%(4.2%)(43,285)(51)(1,068)1(0)(6.6%)(29,023)264

0.0%(42,217)238

0.0%

352,53750.9%

342,27852.3%

692,520100.0%

654,818

100.0%

(2) Consolidated Statements of Income(Millions of yen)

For three months ended
June 30, 2011
AmountI Net sales
II Cost of sales
Gross profit
III Selling, general and administrative expensesOperating income
IV Non-operating income%

For three months ended
June 30, 2012
Amount%95,630100.0%

95,867100.0%

44,78746.8%

44,17546.1%

50,842
33,463

53.2%
35.0%

51,692
36,211

53.9%
37.8%

17,37818.2%

15,481

16.1%

514

0.5%

Interest income

8664

Dividends income

154

56

Royalty income

3728

Equity in earnings of affiliates

33

33

Other

91

402

0.4%

331

V Non-operating expenses
Interest expenses

161

263

Sales discounts

154

Foreign exchange losses

146
451

2,410

Loss on disposal of inventories

530

Other

99

Ordinary income
VI Extraordinary income
Gain on sales of noncurrent assets
Reversal of provision for loss on disaster

12156

Subsidy income

227

913

1.0%

16,868

17.6%

185

3,013

3.1%

12,981

13.5%

875

0.9%

0395

0.4%

－875

VII Extraordinary expenses
Loss on disposal of noncurrent assets

4

Loss on valuation of investment securities

1,112

Income before income taxes
Income taxes-current

5,751

Income taxes-deferred

613

Income before minority interests
Minority interests in income

Net income

481
1,116

1.1%

16,147

16.9%

－81

0.0%

13,776

14.4%

3,991
6,365

6.7%

5,600

5.9%

9,781
9

10.2%
0.0%

1,609

8,175
16

8.5%
0.0%

9,772

10.2%

8,159

8.5%

(3) Consolidated statement of comprehensive income(Millions of yen)

For three months ended
June 30, 2011

For three months ended
June 30, 2012

AmountAmountI Income before minority interests
II Othercomprehensive
incomeValuationdifference on
available-for-salesecurities

9,781

8,175

Valuation difference on available-for-sale securities

2,183(1,016)

Deferred gains or losses on hedges
Foreign currency translation adjustments
Share of other comprehensive income of associates
accounted for using equity method(3,612)(2,437)(1)(13,237)(0)Comprehensive income(3,867)(1)(14,256)

5,914(6,081)

5,914(6,054)(0)(26)

Attributable to:Shareholders of Terumo Corporation
Minority interests

56. Segment Information[Reportable Segments](1) The First Quarter of Fiscal Year Ended March 31, 2012
For three months ended
June 30, 2011
GeneralHospitalBusiness

Cardiac &VascularBusiness

BloodManagementBusiness(Millions of yen)

Subtotal

Adjustment

Total

Sales and operating income:Sales to customer

37,632

39,95518,042

95,630－－－－－－－

Sales total

37,632

39,95518,042

95,630－95,630

Segment income (loss)

7,813
9,629
1,561
19,004(1,625)
17,378
1. The (1,625) million yen adjustment to segment profit is the sum of the (2,712)

Internal sales

Notes:

95,630

million yen for inventories and the 1,086 million yen for others.
2. Segment profit is adjusted to be consistent with operating income shown on thequarterly consolidated income statement.
(Additional Information)
From the first quarter of fiscal year ended March 31, 2012, Caridian BCT Holding Corp. is newly added to Terumo
group as a consolidating subsidiary with an acquisition of 100% of its shares.
As a unit of reportable segments, the business of BCT is classified as Blood Management Business.
From this effect, goodwill had increased by 124,427 million yen for the first quarter of fiscal year ended March, 31,2012.
(2) The First Quarter of Fiscal Year Ending March 31, 2013
For three months ended
June 30, 2012
GeneralHospitalBusinessCardiac &VascularBusinessBloodManagementBusiness(Millions of yen)

SubtotalAdjustmentTotal

Sales and operating income:Sales to customer

38,182

41,056

16,62895,867－－－－－－－

Sales total

38,182

41,056

16,62895,867－

95,867

Segment income (loss)

5,959
6,859
287
13,1062,374
15,481
1. The 2,374 million yen adjustment to segment profit is the sum of the 1,300

Internal sales

Notes:

95,867

million yen for inventories and the 1,073 million yen for others.
2. Segment profit is adjusted to be consistent with operating income shown on thequarterly consolidated income statement.
(Additional Information)
From the first quarter of fiscal year ending March 31, 2013, Consumer Healthcare Business has been integrated into
General Hospital Business and the reportable segments has been changed from 4 segments to 3 segments, General
Hospital Business, Cardiac & Vascular Business, and Blood Management Business. The purpose of this organization
change is to correspond with the rapidly and sophisticatedly changing healthcare market and the arising healthcare
consciousness, to manage and strongly implement strategies with customer characteristics as center.
The segment information of the first quarter of Fiscal Year Ended March 31, 2012, is disclosed in line with thereportable segments after the organization change.

(Note) Main products belonging to each business segment

Business segments

Main products

General Hospital Business
Disposable medical devices
and Medical electronics

Syringes, Needles, Blood collection tubes, Home parenteral nutrition system,
Solution sets, I.V.catheters, Infusion pumps, Syringe pumps, Home oxygen therapysystem, etc.

Pharmaceuticals

I.V.solutions, Nutritious food, Prefilled syringes, CAPD systems, etc.

Diabetes care products

Blood glucose monitoring systems

Consumer Healthcare products

Digital thermometers, Blood pressure monitors, Blood glucose monitors (OTC), etc.

Cardiac & Vascular Business
Interventional systems

Angiographic catheters, PTCA balloon catheters, Coronary stents, Neuro interventionalcoils, etc.

Cardiovascular systems

Oxygenerators, Cardio-pulmonary bypass system, LVA system, etc.

Vascular grafts

Artificial vascular grafts, Stent grafts

Blood Management Business

Blood bags, Automated blood processing, Therapeutic aphaeresis, Cell therapy, etc.

6